Boxer Capital Management as of March 31, 2026
Portfolio Holdings for Boxer Capital Management
Boxer Capital Management holds 54 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Tango Therapeutics (TNGX) | 29.9 | $228M | 11M | 20.92 | |
| Kodiak Sciences (KOD) | 6.8 | $52M | 1.4M | 38.12 | |
| Revolution Medicines (RVMD) | 6.4 | $49M | 500k | 97.25 | |
| Kymera Therapeutics (KYMR) | 3.6 | $27M | 329k | 83.29 | |
| Celcuity (CELC) | 3.4 | $26M | 225k | 114.14 | |
| Surrozen Com New (SRZN) | 2.9 | $22M | 766k | 29.13 | |
| Abivax Sa Sponsored Ads (ABVX) | 2.9 | $22M | 200k | 111.35 | |
| Terns Pharmaceuticals (TERN) | 2.6 | $20M | 375k | 52.72 | |
| Vaxcyte (PCVX) | 2.5 | $19M | 325k | 58.11 | |
| Capricor Therapeutics Com New (CAPR) | 2.4 | $18M | 590k | 30.40 | |
| Protagonist Therapeutics (PTGX) | 2.4 | $18M | 170k | 105.40 | |
| Vir Biotechnology (VIR) | 2.2 | $17M | 1.9M | 8.96 | |
| Corvus Pharmaceuticals (CRVS) | 2.1 | $16M | 1.1M | 14.63 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.0 | $15M | 47k | 322.19 | |
| Ptc Therapeutics I (PTCT) | 1.8 | $14M | 200k | 68.13 | |
| Precigen (PGEN) | 1.8 | $14M | 3.5M | 3.87 | |
| Definium Therapeutics Com Shs (DFTX) | 1.5 | $11M | 599k | 18.90 | |
| Amylyx Pharmaceuticals (AMLX) | 1.5 | $11M | 800k | 13.90 | |
| Uniqure Nv SHS (QURE) | 1.4 | $11M | 662k | 16.35 | |
| Ocuphire Pharma (IRD) | 1.3 | $10M | 2.3M | 4.55 | |
| Corcept Therapeutics Incorporated (CORT) | 1.3 | $10M | 250k | 40.31 | |
| Urogen Pharma (URGN) | 1.2 | $9.0M | 500k | 17.98 | |
| Replimune Group (REPL) | 1.2 | $9.0M | 1.2M | 7.65 | |
| Cogent Biosciences (COGT) | 1.1 | $8.7M | 225k | 38.49 | |
| Palisade Bio (PALI) | 1.1 | $8.4M | 4.8M | 1.75 | |
| Crescent Biopharma | 1.1 | $8.3M | 454k | 18.37 | |
| Soleno Therapeutics | 0.9 | $6.7M | 200k | 33.48 | |
| Allogene Therapeutics (ALLO) | 0.9 | $6.6M | 2.7M | 2.44 | |
| Cytokinetics Com New (CYTK) | 0.9 | $6.6M | 100k | 65.91 | |
| Contineum Therapeutics Cl A (CTNM) | 0.8 | $6.5M | 494k | 13.06 | |
| Apogee Therapeutics (APGE) | 0.8 | $5.9M | 70k | 84.17 | |
| Relmada Therapeutics (RLMD) | 0.8 | $5.9M | 842k | 6.96 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.7 | $5.4M | 900k | 5.95 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.7 | $5.1M | 275k | 18.64 | |
| Avalo Therapeutics Com New (AVTX) | 0.6 | $4.5M | 300k | 14.93 | |
| Inovio Pharmaceuticals Com Shs (INO) | 0.5 | $4.1M | 2.4M | 1.74 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.5 | $3.6M | 75k | 48.20 | |
| Sarepta Therapeutics (SRPT) | 0.4 | $3.3M | 150k | 21.76 | |
| Cybin Com New (HELP) | 0.4 | $3.1M | 640k | 4.80 | |
| Ocular Therapeutix (OCUL) | 0.4 | $3.0M | 350k | 8.47 | |
| An2 Therapeutics (ANTX) | 0.3 | $2.6M | 749k | 3.42 | |
| Clene Com New (CLNN) | 0.3 | $2.4M | 478k | 4.93 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $2.2M | 177k | 12.67 | |
| Solid Biosciences Com New (SLDB) | 0.3 | $2.2M | 300k | 7.20 | |
| Adagio Therapeutics (IVVD) | 0.3 | $2.0M | 1.5M | 1.30 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 0.2 | $1.7M | 70k | 24.66 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.2 | $1.7M | 303k | 5.57 | |
| Nurix Therapeutics (NRIX) | 0.2 | $1.6M | 100k | 15.50 | |
| Upstream Bio (UPB) | 0.2 | $1.4M | 150k | 9.00 | |
| Milestone Pharmaceuticals (MIST) | 0.1 | $793k | 667k | 1.19 | |
| Pepgen (PEPG) | 0.1 | $483k | 273k | 1.77 | |
| Kalvista Pharmaceuticals | 0.1 | $411k | 20k | 20.13 | |
| Regenxbio Inc equity us cm (RGNX) | 0.0 | $126k | 15k | 8.38 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $1.1k | 67k | 0.02 |
